DOCSLIB.ORG

Structural Basis for Mutual Relief of the Rac Guanine Nucleotide Exchange Factor DOCK2 and Its Partner ELMO1 from Their Autoinhibited Forms

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Structural Basis for Mutual Relief of the Rac Guanine Nucleotide Exchange Factor DOCK2 and Its Partner ELMO1 from Their Autoinhibited Forms Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited forms Kyoko Hanawa-Suetsugua, Mutsuko Kukimoto-Niinoa,b, Chiemi Mishima-Tsumagaria, Ryogo Akasakaa, Noboru Ohsawaa, Shun-ichi Sekinea,c, Takuhiro Itoa,c, Naoya Tochioa, Seizo Koshibaa, Takanori Kigawaa,d, Takaho Teradaa,b, Mikako Shirouzua, Akihiko Nishikimib,e,f, Takehito Urunoe, Tomoya Katakaig, Tatsuo Kinashig, Daisuke Kohdah, Yoshinori Fukuib,e,f,1, and Shigeyuki Yokoyamaa,b,c,1 aRIKEN Systems and Structural Biology Center, 1-7-22 Suehiro, Tsurumi, Yokohama 230-0045, Japan; bJapan Science and Technology Agency, Core Research for Evolutional Science and Technology, Tokyo 102-0075, Japan; cDepartment of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan; dTokyo Institute of Technology, 4259 Nagatsuta, Midori, Yokohama 226-8502, Japan; eDivision of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan; fResearch Center for Advanced Immunology, Kyushu University, Fukuoka 812-8582, Japan; gDepartment of Molecular Genetics, Institute of Biomedical Science, Kansai Medical University, Osaka 570-8506, Japan; and hDivision of Structural Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan Edited by John Kuriyan, University of California, Berkeley, CA, and approved December 31, 2011 (received for review September 6, 2011) DOCK2, a hematopoietic cell-specific, atypical guanine nucleotide for the Rho-family GTPases. There are 11 mammalian members exchange factor, controls lymphocyte migration through ras-related (DOCK180, DOCK2-11) of the CDM family. The CDM proteins C3 botulinum toxin substrate (Rac) activation. Dedicator of cytokin- share the DOCK-homology regions (DHR)-1 and DHR-2 (also esis 2–engulfment and cell motility protein 1 (DOCK2•ELMO1) com- known as Docker domains), and lack the Dbl homology (DH) plex formation is required for DOCK2-mediated Rac signaling. In this and pleckstrin homology (PH) domains typically present in the study, we identified the N-terminal 177-residue fragment and the mammalian Rho-family GEFs (6, 9, 10). DOCK2 mediates the C-terminal 196-residue fragment of human DOCK2 and ELMO1, re- Rac GEF reaction by means of the DHR-2 domain (6, 10, 11). spectively, as the mutual binding regions, and solved the crystal DOCK2 also interacts with phosphatidylinositol 3,4,5-tripho- structure of their complex at 2.1-Å resolution. The C-terminal Pro- sphate [PtdInsð3;4;5ÞP3] through the DHR-1 domain (7, 12), to rich tail of ELMO1 winds around the Src-homology 3 domain of target the GEF activity to the plasma membrane. Recently, the DOCK2, and an intermolecular five-helix bundle is formed. Overall, crystal structure of the DHR-1 domain of DOCK180 was deter- the entire regions of both DOCK2 and ELMO1 assemble to create a mined (13), as well as those of the DHR-2 domains of DOCK2 rigid structure, which is required for the DOCK2•ELMO1 binding, as and DOCK9 bound with their substrates, Rac1 and cell division revealed by mutagenesis. Intriguingly, the DOCK2•ELMO1 interface cycle 42 (Cdc42), respectively (14, 15). BIOCHEMISTRY hydrophobically buries a residue which, when mutated, reportedly DOCK2, like DOCK180 and DOCK3-5, has a Src-homology relieves DOCK180 from autoinhibition. We demonstrated that the 3 (SH3) domain at its N terminus. The N-terminal 502-residue re- ELMO-interacting region and the DOCK-homology region 2 guanine gion, including the SH3 domain, of DOCK2 interacts with engulf- nucleotide exchange factor domain of DOCK2 associate with each ment and cell motility protein 1 (ELMO1), a mammalian other for the autoinhibition, and that the assembly with ELMO1 homologue of C. elegans CED-12 (16). ELMO1 contains the N- weakens the interaction, relieving DOCK2 from the autoinhibition. terminal ras homolog gene family, member G (RhoG)-binding re- The interactions between the N- and C-terminal regions of ELMO1 gion, the ELMO domain, the PH domain, and the C-terminal se- reportedly cause its autoinhibition, and binding with a DOCK quence with three PxxP motifs. The C-terminal region of ELMO1, protein relieves the autoinhibition for ras homolog gene family, including the Pro-rich sequence, binds the SH3-containing region member G binding and membrane localization. In fact, the DOCK2•- of DOCK2, which is required for DOCK2 to activate Rac in vivo (16). Similarly, DOCK180 forms a ternary complex with ELMO1 ELMO1 interface also buries the ELMO1 residues required for the and Rac (17, 18), which is essential for the in vivo catalytic activity autoinhibition within the hydrophobic core of the helix bundle. (17, 19). ELMO1 binds to the N-terminal region (about 200 resi- Therefore, the present complex structure reveals the structural basis dues), including the SH3 domain, of DOCK180 (17, 19). However, by which DOCK2 and ELMO1 mutually relieve their autoinhibition an ELMO1 mutant lacking the Pro-rich sequence retains the ability for the activation of Rac1 for lymphocyte chemotaxis. to bind DOCK180 (20), suggesting that the region flanking the Pro- ∣ ∣ ∣ ∣ rich sequence of ELMO1 also participates in DOCK180 binding. X-ray crystallography NMR protein complex CDM proteins Furthermore, the DOCK180•ELMO1 complex was proposed to immunology function as a bipartite GEF for Rac, in which the DHR-2 domain edicator of cytokinesis 2 (DOCK2), a large protein with a Dmolecular mass of 213 kDa, is specifically expressed in he- Author contributions: M.S., Y.F., and S.Y. designed research; K.H.-S., M.K.-N., C.M.-T., R.A., matopoietic cells (1). DOCK2 plays a critical role in lymphocyte N.O., S.-i.S., T.I., N.T., S.K., T. Kigawa, T.T., A.N., T.U., D.K., and S.Y. performed research; T. Katakai and T. Kinashi contributed new reagents/analytic tools; K.H.-S., M.K.-N., Y.F., migration and activation by regulating the actin cytoskeleton and S.Y. analyzed data; and K.H.-S., M.K.-N., Y.F., and S.Y. wrote the paper. through ras-related C3 botulinum toxin substrate (Rac) activa- The authors declare no conflict of interest. tion (2, 3), and the deletion of DOCK2 enables long-term cardiac This article is a PNAS Direct Submission. allograft survival (4). DOCK2 also controls various immunolo- Freely available online through the PNAS open access option. gical functions, including helper Tcell differentiation (5), neutro- Data deposition: The atomic coordinates have been deposited in the Protein Data Bank, phil chemotaxis (6, 7), and type I interferon induction in plasma- www.pdb.org (PDB ID codes 2RQR, 3A98, 3B13). cytoid dendritic cells (8). DOCK2 belongs to the CDM family 1To whom correspondence may be addressed. E-mail: [email protected] (Caenorhabditis elegans CED-5, mammalian DOCK180, and or [email protected]. Drosophila melanogaster Myoblast city) of the evolutionally con- This article contains supporting information online at www.pnas.org/lookup/suppl/ served, atypical guanine nucleotide exchange factors (GEFs) doi:10.1073/pnas.1113512109/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1113512109 PNAS ∣ February 28, 2012 ∣ vol. 109 ∣ no. 9 ∣ 3305–3310 Downloaded by guest on September 30, 2021 of DOCK180 and the PH domain of ELMO1 cooperatively func- tion (20). The crystal structure of the ELMO1 PH domain has re- cently been determined, and the unusual α-helical N-terminal extension of the PH domain in ELMO1 was found to be essential for DOCK180 binding and DOCK180-mediated Rac signal- ing (21). In the absence of ELMO1, the N-terminal region, including the SH3 domain, of DOCK180 interacts with the DHR-2 domain, which may facilitate the autoinhibition of the DOCK180 GEF activity (22). ELMO1 binding to the SH3 domain disrupts the SH3•DHR-2 interaction, and allows Rac binding to the DHR-2 domain for the GEF activity (22). This autoinhibition of DOCK180 is relieved by the mutation of Ile31 in the SH3 do- main, even though the location of this residue is distant from the PxxP-binding pocket. ELMO1 by itself is also reportedly auto- inhibited because of the interaction of the ELMO inhibitory do- main (EID), lying between the C-terminal PxxP motif and the PH domain, with the ELMO autoregulatory domain (EAD) residing between the N-terminal RhoG-binding domain and the ELMO domain. Actually, EAD binding to DOCK180, as well as the mutations of Met692 and Glu693 in the EAD, disrupts this intra- Fig. 1. Mutually interactive regions of DOCK2 and ELMO1. (A) Domain or- molecular inhibitory interaction, resulting in RhoG binding and ganizations of DOCK2 and ELMO1. Known protein interaction and functional membrane localization (23). Consequently, DOCK2 and ELMO1 regions are indicated. Blue and red bars indicate the DOCK2 and ELMO1 mutually relieve their autoinhibitions by an unknown interaction regions included in the NMR construct. Green and yellow bars indicate the mode involving the DOCK2 N-terminal and ELMO1 C-terminal regions used for the crystal structure determination. ELMO1-interacting re- regions, a scenario that is far more complicated than simple gion (EIR) and DOCK2-interacting region (DIR) indicate the ELMO1-interact- SH3•PxxP binding. ing region and the DOCK2-interacting region, respectively. (B) Overviews of In the present study, we identified the regions required for the the crystal structure of the DOCK2•ELMOl complex. Ribbon representations • interaction between DOCK2 and ELMO1, and determined their of the DOCK2 ELMOl complex. DOCK2 is colored green and ELMO1 is yellow. The six proline residues in the ELMO1 Pro-rich tail are colored red. The two complex structure. The SH3 domain of DOCK2 binds to the views are related by a 90° rotation about the vertical axis. C-terminal sequence of ELMO1 much more extensively than other SH3 domains, which only bind the PxxP motif.
Load more

Recommended publications
  • Dock3 Protects Myelin in the Cuprizone Model for Demyelination
    Citation: Cell Death and Disease (2014) 5, e1395; doi:10.1038/cddis.2014.357 OPEN & 2014 Macmillan Publishers Limited All rights reserved 2041-4889/14 www.nature.com/cddis Dock3 protects myelin in the cuprizone model for demyelination K Namekata1, A Kimura1, C Harada1, H Yoshida2, Y Matsumoto1 and T Harada*,1,2 Dedicator of cytokinesis 3 (Dock3) belongs to an atypical family of the guanine nucleotide exchange factors. It is predominantly expressed in the neural tissues and causes cellular morphological changes by activating the small GTPase Rac1. We previously reported that Dock3 overexpression protects retinal ganglion cells from excitotoxic cell death. Oligodendrocytes are the myelinating cells of axons in the central nervous system and these cells are damaged in demyelinating disorders including multiple sclerosis (MS) and optic neuritis. In this study, we examined if Dock3 is expressed in oligodendrocytes and if increasing Dock3 signals can suppress demyelination in a cuprizone-induced demyelination model, an animal model of MS. We demonstrate that Dock3 is expressed in oligodendrocytes and Dock3 overexpression protects myelin in the corpus callosum following cuprizone treatment. Furthermore, we show that cuprizone demyelinates optic nerves and the extent of demyelination is ameliorated in mice overexpressing Dock3. Cuprizone treatment impairs visual function, which was demonstrated by multifocal electroretinograms, an established non-invasive method, and Dock3 overexpression prevented this effect. In mice overexpressing Dock3, Erk activation is increased, suggesting this may at least partly explain the observed protective effects. Our findings suggest that Dock3 may be a therapeutic target for demyelinating disorders including optic neuritis. Cell Death and Disease (2014) 5, e1395; doi:10.1038/cddis.2014.357; published online 28 August 2014 Dedicator of cytokinesis 3 (Dock3), an atypical member of the will restore the visual function.
    [Show full text]
  • Structure of the Dock2âˆ'elmo1 Complex Provides Insights Into
    ARTICLE https://doi.org/10.1038/s41467-020-17271-9 OPEN Structure of the DOCK2−ELMO1 complex provides insights into regulation of the auto-inhibited state Leifu Chang1,7, Jing Yang1, Chang Hwa Jo 2, Andreas Boland 1,8, Ziguo Zhang 1, Stephen H. McLaughlin 1, Afnan Abu-Thuraia 3, Ryan C. Killoran2, Matthew J. Smith 2,4,9, Jean-Francois Côté 3,5,6,9 & ✉ David Barford 1 DOCK (dedicator of cytokinesis) proteins are multidomain guanine nucleotide exchange 1234567890():,; factors (GEFs) for RHO GTPases that regulate intracellular actin dynamics. DOCK proteins share catalytic (DOCKDHR2) and membrane-associated (DOCKDHR1) domains. The structurally-related DOCK1 and DOCK2 GEFs are specific for RAC, and require ELMO (engulfment and cell motility) proteins for function. The N-terminal RAS-binding domain (RBD) of ELMO (ELMORBD) interacts with RHOG to modulate DOCK1/2 activity. Here, we determine the cryo-EM structures of DOCK2−ELMO1 alone, and as a ternary complex with RAC1, together with the crystal structure of a RHOG−ELMO2RBD complex. The binary DOCK2−ELMO1 complex adopts a closed, auto-inhibited conformation. Relief of auto- inhibition to an active, open state, due to a conformational change of the ELMO1 subunit, exposes binding sites for RAC1 on DOCK2DHR2, and RHOG and BAI GPCRs on ELMO1. Our structure explains how up-stream effectors, including DOCK2 and ELMO1 phosphorylation, destabilise the auto-inhibited state to promote an active GEF. 1 MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK. 2 Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada. 3 Montreal Institute of Clinical Research (IRCM), Montréal, QC H2W 1R7, Canada.
    [Show full text]
  • Pi3kp110-, Src-, FAK-Dependent and DOCK2-Independent Migration and Invasion of CXCL13-Stimulated Prostate Cancer Cells
    El Haibi et al. Molecular Cancer 2010, 9:85 http://www.molecular-cancer.com/content/9/1/85 RESEARCH Open Access PI3Kp110-,Research Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells Christelle P El Haibi1, Praveen K Sharma2, Rajesh Singh3, Paul R Johnson4, Jill Suttles2, Shailesh Singh3 and James W Lillard Jr*3 Abstract Background: Most prostate cancer (PCa)-related deaths are due to metastasis, which is mediated in part by chemokine receptor and corresponding ligand interaction. We have previously shown that PCa tissue and cell lines express high levels of the chemokine receptor CXCR5, than compared to their normal counterparts, and interaction of CXCR5 with its specific ligand (CXCL13) promoted PCa cell invasion, migration, and differential matrix metalloproteinase (MMP) expression. This study dissects some of the molecular mechanisms following CXCL13-CXCR5 interaction that mediate PCa cell migration and invasion. Results: Using Western blot analysis, kinase-specific cell-based ELISAs, and migration and invasion assays, we show that PCa cell lines differentially express phosphoinositide-3 kinase (PI3K) catalytic subunit isoforms and dedicator of cytokinesis 2 (DOCK2). Specifically, we show that PC3 and normal prostatic epithelial (RWPE-1), but not LNCaP cell lines expressed DOCK2, while RWPE, PC3, and LNCaP cell lines expressed PI3K-p110α and -p110β. Moreover, PC3 selectively expressed PI3K-p110γ, but LNCaP and RWPE cell lines expressed PI3Kp110δ. CXCL13 caused CXCR5-dependent activation of the PI3Kp85α in LNCaP cells, and p85α as well as -p101 in PC3 cells. CXCL13-CXCR5 interaction regulated LNCaP and PC3 cell migration and invasion through extracellular signal-regulated kinase 1/2 (ERK1/2) activation that was primarily dependent on the PI3Kp110 isoform(s), Src, and focal adhesion kinase (FAK), but not DOCK2.
    [Show full text]
  • CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma
    International Journal of Molecular Sciences Article CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma 1, 2,3,4, 5 6 7 Ju-Fang Liu y, Chiang-Wen Lee y, Chih-Yang Lin , Chia-Chia Chao , Tsung-Ming Chang , Chien-Kuo Han 8, Yuan-Li Huang 8, Yi-Chin Fong 9,10,* and Chih-Hsin Tang 8,11,12,* 1 School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei City 11031, Taiwan; [email protected] 2 Department of Orthopaedic Surgery, Chang Gung Memorial Hospital, Puzi City, Chiayi County 61363, Taiwan; [email protected] 3 Department of Nursing, Division of Basic Medical Sciences, and Chronic Diseases and Health Promotion Research Center, Chang Gung University of Science and Technology, Puzi City, Chiayi County 61363, Taiwan 4 Research Center for Industry of Human Ecology and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Guishan Dist., Taoyuan City 33303, Taiwan 5 School of Medicine, China Medical University, Taichung 40402, Taiwan; [email protected] 6 Department of Respiratory Therapy, Fu Jen Catholic University, New Taipei City 24205, Taiwan; [email protected] 7 School of Medicine, Institute of Physiology, National Yang-Ming University, Taipei City 11221, Taiwan; [email protected] 8 Department of Biotechnology, College of Health Science, Asia University, Taichung 40402, Taiwan; [email protected] (C.-K.H.); [email protected] (Y.-L.H.) 9 Department of Sports Medicine, College of Health Care, China Medical University, Taichung 40402, Taiwan 10 Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin 65152, Taiwan 11 Department of Pharmacology, School of Medicine, China Medical University, Taichung 40402, Taiwan 12 Chinese Medicine Research Center, China Medical University, Taichung 40402, Taiwan * Correspondence: [email protected] (Y.-C.F.); [email protected] (C.-H.T.); Tel.: +886-4-2205-2121-7726 (C.-H.T.); Fax: +886-4-2233-3641 (C.-H.T.) These authors contributed equally to this work.
    [Show full text]
  • A Rac/Cdc42 Exchange Factor Complex Promotes Formation of Lateral filopodia and Blood Vessel Lumen Morphogenesis
    ARTICLE Received 1 Oct 2014 | Accepted 26 Apr 2015 | Published 1 Jul 2015 DOI: 10.1038/ncomms8286 OPEN A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis Sabu Abraham1,w,*, Margherita Scarcia2,w,*, Richard D. Bagshaw3,w,*, Kathryn McMahon2,w, Gary Grant2, Tracey Harvey2,w, Maggie Yeo1, Filomena O.G. Esteves2, Helene H. Thygesen2,w, Pamela F. Jones4, Valerie Speirs2, Andrew M. Hanby2, Peter J. Selby2, Mihaela Lorger2, T. Neil Dear4,w, Tony Pawson3,z, Christopher J. Marshall1 & Georgia Mavria2 During angiogenesis, Rho-GTPases influence endothelial cell migration and cell–cell adhesion; however it is not known whether they control formation of vessel lumens, which are essential for blood flow. Here, using an organotypic system that recapitulates distinct stages of VEGF-dependent angiogenesis, we show that lumen formation requires early cytoskeletal remodelling and lateral cell–cell contacts, mediated through the RAC1 guanine nucleotide exchange factor (GEF) DOCK4 (dedicator of cytokinesis 4). DOCK4 signalling is necessary for lateral filopodial protrusions and tubule remodelling prior to lumen formation, whereas proximal, tip filopodia persist in the absence of DOCK4. VEGF-dependent Rac activation via DOCK4 is necessary for CDC42 activation to signal filopodia formation and depends on the activation of RHOG through the RHOG GEF, SGEF. VEGF promotes interaction of DOCK4 with the CDC42 GEF DOCK9. These studies identify a novel Rho-family GTPase activation cascade for the formation of endothelial cell filopodial protrusions necessary for tubule remodelling, thereby influencing subsequent stages of lumen morphogenesis. 1 Institute of Cancer Research, Division of Cancer Biology, 237 Fulham Road, London SW3 6JB, UK.
    [Show full text]
  • Tyr724 Phosphorylation of ELMO1 by Src Is Involved in Cell Spreading and Migration Via Rac1 Activation
    Title Tyr724 phosphorylation of ELMO1 by Src is involved in cell spreading and migration via Rac1 activation Makino, Yoshinori; Tsuda, Masumi; Ohba, Yusuke; Nishihara, Hiroshi; Sawa, Hirofumi; Nagashima, Kazuo; Tanaka, Author(s) Shinya Cell communication and signaling, 13, 35 Citation https://doi.org/10.1186/s12964-015-0113-y Issue Date 2015-07-26 Doc URL http://hdl.handle.net/2115/59828 Rights(URL) http://creativecommons.org/licenses/by/4.0 Type article File Information s12964-015-0113-y.pdf Instructions for use Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP Makino et al. Cell Communication and Signaling (2015) 13:35 DOI 10.1186/s12964-015-0113-y RESEARCH ARTICLE Open Access Tyr724 phosphorylation of ELMO1 by Src is involved in cell spreading and migration via Rac1 activation Yoshinori Makino1,2, Masumi Tsuda1, Yusuke Ohba3, Hiroshi Nishihara4, Hirofumi Sawa1,5, Kazuo Nagashima1,6 and Shinya Tanaka1,4* Abstract Background: The complex of Dock180/ELMO1 that functions as a bipartite guanine nucleotide exchange factor for Rac is essential for diverse physiological and pathological processes of cells such as cell migration, phagocytosis, and invasion of cancer cells. Among the Src-family tyrosine kinases (SFKs), it has been reported that Hck directly phosphorylates ELMO1, regulating phagocytosis by promoting activation of Rac1; however, the involvement of other SFKs in ELMO1 phosphorylation has remained unknown. Here, we identified novel tyrosine (Y) residues of ELMO1 phosphorylated by SFKs, and examined the effects on Rac1 activity, cell adhesion, spreading, and cell motility on extracellular matrix (ECM). Results: In this study, we unveiled that Src and Fyn can induce tyrosine phosphorylation of ELMO1 in in vivo and in vitro phosphorylation assays.
    [Show full text]
  • A Rhog-Mediated Signaling Pathway That Modulates Invadopodia Dynamics in Breast Cancer Cells Silvia M
    © 2017. Published by The Company of Biologists Ltd | Journal of Cell Science (2017) 130, 1064-1077 doi:10.1242/jcs.195552 RESEARCH ARTICLE A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells Silvia M. Goicoechea, Ashtyn Zinn, Sahezeel S. Awadia, Kyle Snyder and Rafael Garcia-Mata* ABSTRACT micropinocytosis, bacterial uptake, phagocytosis and leukocyte One of the hallmarks of cancer is the ability of tumor cells to invade trans-endothelial migration (deBakker et al., 2004; Ellerbroek et al., surrounding tissues and metastasize. During metastasis, cancer cells 2004; Jackson et al., 2015; Katoh et al., 2006, 2000; van Buul et al., degrade the extracellular matrix, which acts as a physical barrier, by 2007). Recent studies have revealed that RhoG plays a role in tumor developing specialized actin-rich membrane protrusion structures cell invasion and may contribute to the formation of invadopodia called invadopodia. The formation of invadopodia is regulated by Rho (Hiramoto-Yamaki et al., 2010; Kwiatkowska et al., 2012). GTPases, a family of proteins that regulates the actin cytoskeleton. Invadopodia are actin-rich adhesive structures that form in the Here, we describe a novel role for RhoG in the regulation of ventral surface of cancer cells and allow them to degrade the invadopodia disassembly in human breast cancer cells. Our results extracellular matrix (ECM) (Gimona et al., 2008). Formation of show that RhoG and Rac1 have independent and opposite roles invadopodia involves a series of steps that include the disassembly in the regulation of invadopodia dynamics. We also show that SGEF of focal adhesions and stress fibers, and the relocalization of several (also known as ARHGEF26) is the exchange factor responsible of their components into the newly formed invadopodia (Hoshino for the activation of RhoG during invadopodia disassembly.
    [Show full text]
  • CXCL13/CXCR5 Signaling Axis in Cancer
    Life Sciences 227 (2019) 175–186 Contents lists available at ScienceDirect Life Sciences journal homepage: www.elsevier.com/locate/lifescie Review article CXCL13/CXCR5 signaling axis in cancer T ⁎ Muzammal Hussaina,b,1, Dickson Adahb,c,1, Muqddas Tariqa,b, Yongzhi Lua, Jiancun Zhanga, , ⁎ Jinsong Liua, a Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, 190 Kaiyuan Avenue, Science Park, Guangzhou 510530, PR China b University of Chinese Academy of Sciences, Beijing 100049, PR China c State Key Laboratory of Respiratory Disease, Center for Infection and Immunity, Guangzhou Institutes of Biomedicine and Heath, Chinese Academy of Sciences, 190 Kaiyuan Avenue, Science Park, Guangzhou 510530, PR China ARTICLE INFO ABSTRACT Keywords: The tumor microenvironment comprises stromal and tumor cells which interact with each other through com- Cancer plex cross-talks that are mediated by a variety of growth factors, cytokines, and chemokines. The chemokine CXCL13 ligand 13 (CXCL13) and its chemokine receptor 5 (CXCR5) are among the key chemotactic factors which play CXCR5 crucial roles in deriving cancer cell biology. CXCL13/CXCR5 signaling axis makes pivotal contributions to the Tumor progression development and progression of several human cancers. In this review, we discuss how CXCL13/CXCR5 sig- Tumor immunity naling modulates cancer cell ability to grow, proliferate, invade, and metastasize. Furthermore, we also discuss Immune-evasion the preliminary evidence on context-dependent functioning of this axis within the tumor-immune micro- environment, thus, highlighting its potential dichotomy with respect to anticancer immunity and cancer im- mune-evasion mechanisms. At the end, we briefly shed light on the therapeutic potential or implications of targeting CXCL13/CXCR5 axis within the tumor microenvironment.
    [Show full text]
  • HCC and Cancer Mutated Genes Summarized in the Literature Gene Symbol Gene Name References*
    HCC and cancer mutated genes summarized in the literature Gene symbol Gene name References* A2M Alpha-2-macroglobulin (4) ABL1 c-abl oncogene 1, receptor tyrosine kinase (4,5,22) ACBD7 Acyl-Coenzyme A binding domain containing 7 (23) ACTL6A Actin-like 6A (4,5) ACTL6B Actin-like 6B (4) ACVR1B Activin A receptor, type IB (21,22) ACVR2A Activin A receptor, type IIA (4,21) ADAM10 ADAM metallopeptidase domain 10 (5) ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 (4) ADCY2 Adenylate cyclase 2 (brain) (26) AJUBA Ajuba LIM protein (21) AKAP9 A kinase (PRKA) anchor protein (yotiao) 9 (4) Akt AKT serine/threonine kinase (28) AKT1 v-akt murine thymoma viral oncogene homolog 1 (5,21,22) AKT2 v-akt murine thymoma viral oncogene homolog 2 (4) ALB Albumin (4) ALK Anaplastic lymphoma receptor tyrosine kinase (22) AMPH Amphiphysin (24) ANK3 Ankyrin 3, node of Ranvier (ankyrin G) (4) ANKRD12 Ankyrin repeat domain 12 (4) ANO1 Anoctamin 1, calcium activated chloride channel (4) APC Adenomatous polyposis coli (4,5,21,22,25,28) APOB Apolipoprotein B [including Ag(x) antigen] (4) AR Androgen receptor (5,21-23) ARAP1 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 (4) ARHGAP35 Rho GTPase activating protein 35 (21) ARID1A AT rich interactive domain 1A (SWI-like) (4,5,21,22,24,25,27,28) ARID1B AT rich interactive domain 1B (SWI1-like) (4,5,22) ARID2 AT rich interactive domain 2 (ARID, RFX-like) (4,5,22,24,25,27,28) ARID4A AT rich interactive domain 4A (RBP1-like) (28) ARID5B AT rich interactive domain 5B (MRF1-like) (21) ASPM Asp (abnormal
    [Show full text]
  • Chemokine Ligand 13 Expression Is Abundant in the Tumor Microenvironment and Indicates Poor Prognosis of Kidney Clear Cell Carcinoma
    BIOCELL Tech Science Press 2021 45(3): 589-597 Chemokine Ligand 13 Expression is Abundant in the Tumor Microenvironment and Indicates Poor Prognosis of Kidney Clear Cell Carcinoma MENGDAN WU1;MENGYAO SUN1;QINHUAI LAI1;YIN LU1;YUYIN FU1;YUJIA PENG1;WEIRONG LAI1;LISHI ZENG1; SHENGYAN ZHAO1;YUYAN LI1;ZHIXIONG ZHANG1;XIAOFENG CHEN1;FAN QIAO1;YIWEN ZHANG1,*;SHIJIE ZHOU1,2,*; LANTU GOU1;JINLIANG YANG1,2 1 Department of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China 2 Guangdong Zhongsheng Pharmaceutical Co., Ltd., Shantou, 515041, China Key words: CXCL13, Kidney clear cell carcinoma, Gamma/delta T cells, DNA methylation, Unfavorable survival Abstract: The chemokine ligand 13-chemokine receptor 5 (CXCL13-CXCR5) axis has been characterized as a critical tumor-promoting signaling pathway in the tumor microenvironment (TME) in multiple types of solid tumors. In this study, we analyzed the expression profile of CXCL13 in kidney clear cell carcinoma (KIRC) and its correlation with tumor-infiltrating immune cells (TIICs). A monoclonal antibody against CXCL13 with high affinity and purity was generated in our lab for western blot and immunohistochemistry (IHC). Bioinformatic analysis was performed based on bulk-seq data from the Cancer Genome Atlas (TCGA)-KIRC and single-cell RNA-seq data from scRNASeqDB and PanglaoDB. Results showed that high CXCL13 expression in TME was associated with shorter progression-free survival (PFS), disease-specific survival (DSS), and overall survival (OS). KIRC cell lines, as well as several other cancer cell lines, had negative CXCL13 expression. IHC staining from the Human Protein Atlas (HPA) and our tissue array indicated that CXCL13 might be mainly expressed by TIICs, but not KIRC tumor cells.
    [Show full text]
  • Inflammation in Innate and Adaptive Immune Mechanisms October 28 – 30, 2012 Hilton Grand Wailea Resort | Maui, Hawai’I Organizers: Tom Hamilton and Xiaoxia Li
    45th Annual Meeting of The Society for Leukocyte Biology InflammatIon In Innate and adaptIve Immune mechanIsms October 28 – 30, 2012 Hilton Grand Wailea Resort | Maui, Hawai’i Organizers: Tom Hamilton and Xiaoxia Li abstracts Journal of Leukocyte Biology, Supplement 2012 www.leukocytebiology.org 45th AnnuAl Meeting of the Society for leukocyte Biology inflAMMAtion in innAte And AdAptive iMMune MechAniSMS grAnd WAileA, MAui, hAWAi’i ~ octoBer 28-30, 2012 Thank you to the supporters of the 2012 SLB Meeting! Journal of Leukocyte Biology Supplement 2012 ABSTRACTS 1 2 Alcohol and Drugs of Abuse Interaction with HIV/AIDS: Chronic Alcohol Consumption Increases Mortality in Sepsis Systems Biology Approach in the SIV-Infected Macaque Benyam P. Yoseph, Zhe Liang, Elise Breed, Kevin McConnell, Patricia E. Molina David M. Guidot, Michael Koval, Craig M. Coopersmith Comprehensive Alcohol Research Center, Louisiana State Emory University School of Medicine University Health Sciences Center, NOLA Introduction: Excessive alcohol abuse is a problem of particular The two most commonly used and abused drugs are alcohol concern in the intensive care unit (ICU), as the rate of morbidity and the cannabinoids. Alcohol and drugs of abuse have been and mortality in all patients admitted to ICU is 2-4 times greater demonstrated to alter host response to human immunodeficiency than in non-alcoholics. Sepsis is the leading cause of death in ICU. (HIV) infection; by affecting progression of infection, tissue The purpose of this study was to examine the pathophysiology of injury, and time to death. Several factors can be involved in chronic alcohol abuse in sepsis. this, those pertaining to the host response, as well as those Methods: FVB/N mice were given liquid ethanol diet (20% w/v) or related to the ability of the virus to integrate itself into the host water for 12 weeks.
    [Show full text]
  • Identification of Two Signaling Submodules Within the Crkii/ELMO
    Cell Death and Differentiation (2007) 14, 963–972 & 2007 Nature Publishing Group All rights reserved 1350-9047/07 $30.00 www.nature.com/cdd Identification of two signaling submodules within the CrkII/ELMO/Dock180 pathway regulating engulfment of apoptotic cells A-C Tosello-Trampont1,4, JM Kinchen1,2,4, E Brugnera1,3, LB Haney1, MO Hengartner2 and KS Ravichandran*,1 Removal of apoptotic cells is a dynamic process coordinated by ligands on apoptotic cells, and receptors and other signaling proteins on the phagocyte. One of the fundamental challenges is to understand how different phagocyte proteins form specific and functional complexes to orchestrate the recognition/removal of apoptotic cells. One evolutionarily conserved pathway involves the proteins cell death abnormal (CED)-2/chicken tumor virus no. 10 (CT10) regulator of kinase (Crk)II, CED-5/180 kDa protein downstream of chicken tumor virus no. 10 (Crk) (Dock180), CED-12/engulfment and migration (ELMO) and MIG-2/RhoG, leading to activation of the small GTPase CED-10/Rac and cytoskeletal remodeling to promote corpse uptake. Although the role of ELMO : Dock180 in regulating Rac activation has been well defined, the function of CED-2/CrkII in this complex is less well understood. Here, using functional studies in cell lines, we observe that a direct interaction between CrkII and Dock180 is not required for efficient removal of apoptotic cells. Similarly, mutants of CED-5 lacking the CED-2 interaction motifs could rescue engulfment and migration defects in CED-5 deficient worms. Mutants of CrkII and Dock180 that could not biochemically interact could colocalize in membrane ruffles.
    [Show full text]